Karam F.A. Soliman is the Associate Dean for Research and Graduate Studies and Distinguished Professor of Pharmaceutical Sciences at the College of Pharmacy and Pharmaceutical Sciences Institute of Public Health of Florida A&M University (FAMU). Dr. Soliman received his M.S. and Ph.D. degrees in Physiology from the University of Georgia in 1971 and 1972. He started his professional career in 1972 as an assistant professor of Physiology at the School of Veterinary Medicine of Tuskegee Institute. He moved to FAMU in 1975, where he was involved with the Research Center in Minority Institution (RCMI) program for 36 years since its inception in 1985. Also, his record includes the training of 30 PhDs in Pharmacology/Toxicology. He has published extensively in national and international refereed journals (203) publications. His record includes one book, five book chapters, and 4 U.S. patents. His research has been supported by NIH, NASA, Office of Naval Research, and Department of Energy grants. During his tenure at FAMU, he was awarded federal grants totaling over $ 96 million. Dr. Soliman's research interests in cancer have been focused on cancer cell pH as a crucial factor in the biological functions of cancer cell proliferation, invasion, metastasis, drug resistance, and apoptosis. Also, the involvement of NRF2 in aging, COVID 19, neurodegeneration, and cancer. Dr. Soliman is a member of the Society for Neuroscience, American Society of Pharmacology and Experimental Therapeutics, American Physiological Society, American Society for Investigative Pathology, Endocrine Society, Society of Experimental Biology and Medicine, and the American Association of Cancer Society. Dr. Yashwant V. Pathak completed Ph.D. in Pharmaceutical Technology from Nagpur University, India and EMBA & MS in Conflict Management from Sullivan University. He is Professor and Associate Dean for Faculty Affairs at College of Pharmacy, University of South Florida. Tampa, Florida. With extensive experience in academia as well as industry, he has more than 300 research publications, including research papers, chapters and reviews, and 3 US patent approved. Dr Pathak has over 62 edited books published, in Nanotechnology, Nutraceuticals and drug delivery systems. He has several edited books in cultural studies and conflict management . He has received several National and International awards including two times Fulbright awards. Dr Pathak is selected as fellow of American Association for the Advancement of Sciences (FAAAS) in 2021. Dr Yashwant Pathak is also an Adjunct Professor at Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.

• Flavonoids : Sources and Pharmacognastic Characterizations. Flavonoids Classification and Their Applications as Nutraceuticals. Basic NRF2 Physiology and Biochemistry. NRF2 and Oxidative Stress and Flavonoid Nutraceuticals. NRF2 Role in Health and Disease. NRF2 and Cancer and Flavonoid Nutraceuticals. NRF2 - Autophagy and Aging Flavonoid Nutraceuticals. NRF2 - Neurodegenerative Diseases and Brain Aging and Flavonoid Nutraceuticals. NRF2 and Ocular Aging and Flavonoid Nutraceuticals. NRF2 – Role in Obesity and Caloric Restriction and Flavonoid Nutraceuticals. NRF2 Cardiovascular Diseases and Aging and Flavonoid Nutraceuticals. NRF2 and Osteoporosis and Flavonoid Nutraceuticals. Flavonoid Nutraceuticals and Aging Populations. Flavonoids Based Functional Foods. Flavonoid Nutraceuticals Market and Future Trends.

Karam F.A. Soliman is the Associate Dean for Research and Graduate Studies and Distinguished Professor of Pharmaceutical Sciences at the College of Pharmacy and Pharmaceutical Sciences Institute of Public Health of Florida A&M University (FAMU). Dr. Soliman received his M.S. and Ph.D. degrees in Physiology from the University of Georgia in 1971 and 1972. He started his professional career in 1972 as an assistant professor of Physiology at the School of Veterinary Medicine of Tuskegee Institute. He moved to FAMU in 1975, where he was involved with the Research Center in Minority Institution (RCMI) program for 36 years since its inception in 1985. Also, his record includes the training of 30 PhDs in Pharmacology/Toxicology. He has published extensively in national and international refereed journals (203) publications. His record includes one book, five book chapters, and 4 U.S. patents. His research has been supported by NIH, NASA, Office of Naval Research, and Department of Energy grants. During his tenure at FAMU, he was awarded federal grants totaling over $ 96 million. Dr. Soliman's research interests in cancer have been focused on cancer cell pH as a crucial factor in the biological functions of cancer cell proliferation, invasion, metastasis, drug resistance, and apoptosis. Also, the involvement of NRF2 in aging, COVID 19, neurodegeneration, and cancer. Dr. Soliman is a member of the Society for Neuroscience, American Society of Pharmacology and Experimental Therapeutics, American Physiological Society, American Society for Investigative Pathology, Endocrine Society, Society of Experimental Biology and Medicine, and the American Association of Cancer Society. Dr. Yashwant V. Pathak completed Ph.D. in Pharmaceutical Technology from Nagpur University, India and EMBA & MS in Conflict Management from Sullivan University. He is Professor and Associate Dean for Faculty Affairs at College of Pharmacy, University of South Florida. Tampa, Florida. With extensive experience in academia as well as industry, he has more than 300 research publications, including research papers, chapters and reviews, and 3 US patent approved. Dr Pathak has over 62 edited books published, in Nanotechnology, Nutraceuticals and drug delivery systems. He has several edited books in cultural studies and conflict management . He has received several National and International awards including two times Fulbright awards. Dr Pathak is selected as fellow of American Association for the Advancement of Sciences (FAAAS) in 2021. Dr Yashwant Pathak is also an Adjunct Professor at Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.

• Flavonoids : Sources and Pharmacognastic Characterizations. Flavonoids Classification and Their Applications as Nutraceuticals. Basic NRF2 Physiology and Biochemistry. NRF2 and Oxidative Stress and Flavonoid Nutraceuticals. NRF2 Role in Health and Disease. NRF2 and Cancer and Flavonoid Nutraceuticals. NRF2 - Autophagy and Aging Flavonoid Nutraceuticals. NRF2 - Neurodegenerative Diseases and Brain Aging and Flavonoid Nutraceuticals. NRF2 and Ocular Aging and Flavonoid Nutraceuticals. NRF2 – Role in Obesity and Caloric Restriction and Flavonoid Nutraceuticals. NRF2 Cardiovascular Diseases and Aging and Flavonoid Nutraceuticals. NRF2 and Osteoporosis and Flavonoid Nutraceuticals. Flavonoid Nutraceuticals and Aging Populations. Flavonoids Based Functional Foods. Flavonoid Nutraceuticals Market and Future Trends.

Karam F.A. Soliman is the Associate Dean for Research and Graduate Studies and Distinguished Professor of Pharmaceutical Sciences at the College of Pharmacy and Pharmaceutical Sciences Institute of Public Health of Florida A&M University (FAMU). Dr. Soliman received his M.S. and Ph.D. degrees in Physiology from the University of Georgia in 1971 and 1972. He started his professional career in 1972 as an assistant professor of Physiology at the School of Veterinary Medicine of Tuskegee Institute. He moved to FAMU in 1975, where he was involved with the Research Center in Minority Institution (RCMI) program for 36 years since its inception in 1985. Also, his record includes the training of 30 PhDs in Pharmacology/Toxicology. He has published extensively in national and international refereed journals (203) publications. His record includes one book, five book chapters, and 4 U.S. patents. His research has been supported by NIH, NASA, Office of Naval Research, and Department of Energy grants. During his tenure at FAMU, he was awarded federal grants totaling over $ 96 million. Dr. Soliman's research interests in cancer have been focused on cancer cell pH as a crucial factor in the biological functions of cancer cell proliferation, invasion, metastasis, drug resistance, and apoptosis. Also, the involvement of NRF2 in aging, COVID 19, neurodegeneration, and cancer. Dr. Soliman is a member of the Society for Neuroscience, American Society of Pharmacology and Experimental Therapeutics, American Physiological Society, American Society for Investigative Pathology, Endocrine Society, Society of Experimental Biology and Medicine, and the American Association of Cancer Society. Dr. Yashwant V. Pathak completed Ph.D. in Pharmaceutical Technology from Nagpur University, India and EMBA & MS in Conflict Management from Sullivan University. He is Professor and Associate Dean for Faculty Affairs at College of Pharmacy, University of South Florida. Tampa, Florida. With extensive experience in academia as well as industry, he has more than 300 research publications, including research papers, chapters and reviews, and 3 US patent approved. Dr Pathak has over 62 edited books published, in Nanotechnology, Nutraceuticals and drug delivery systems. He has several edited books in cultural studies and conflict management . He has received several National and International awards including two times Fulbright awards. Dr Pathak is selected as fellow of American Association for the Advancement of Sciences (FAAAS) in 2021. Dr Yashwant Pathak is also an Adjunct Professor at Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.

• Flavonoids : Sources and Pharmacognastic Characterizations. Flavonoids Classification and Their Applications as Nutraceuticals. Basic NRF2 Physiology and Biochemistry. NRF2 and Oxidative Stress and Flavonoid Nutraceuticals. NRF2 Role in Health and Disease. NRF2 and Cancer and Flavonoid Nutraceuticals. NRF2 - Autophagy and Aging Flavonoid Nutraceuticals. NRF2 - Neurodegenerative Diseases and Brain Aging and Flavonoid Nutraceuticals. NRF2 and Ocular Aging and Flavonoid Nutraceuticals. NRF2 – Role in Obesity and Caloric Restriction and Flavonoid Nutraceuticals. NRF2 Cardiovascular Diseases and Aging and Flavonoid Nutraceuticals. NRF2 and Osteoporosis and Flavonoid Nutraceuticals. Flavonoid Nutraceuticals and Aging Populations. Flavonoids Based Functional Foods. Flavonoid Nutraceuticals Market and Future Trends.